or Try an Advanced Search...

    Technical Analysis for AVIR - Atea Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 3.23 2.28% 0.07
    AVIR closed up 0.64 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AVIR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 2.28%
    Lower Bollinger Band Walk Weakness 2.28%
    BB Squeeze Ended Range Expansion 2.28%
    Lower Bollinger Band Touch Weakness 2.28%
    Oversold Stochastic Weakness 2.28%
    Bollinger Band Squeeze Range Contraction 2.93%
    NR7 Range Contraction 2.93%
    Narrow Range Bar Range Contraction 2.93%
    BB Squeeze + Lower Band Touch Range Contraction 2.93%
    Down 3 Days in a Row Weakness 2.93%
    Older End-of-Day Signals for AVIR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 3 hours ago
    Up 2% about 3 hours ago
    Up 1% about 3 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Possible NR7 about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AVIR Chart by TradingView
    Basic chart:

    Profile

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is AVIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
    Nov 12 Atea Pharmaceuticals Inc (AVIR) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ...
    Nov 9 Atea Pharmaceuticals, Inc. (AVIR) Q3 2024 Earnings Call Transcript
    Nov 7 Atea Pharmaceuticals files for $500M mixed securities shelf
    Nov 7 Atea Pharmaceuticals reports Q3 results
    Nov 7 Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
    Oct 31 Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
    Oct 30 Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
    Oct 21 Atea Pharmaceuticals Leads The Charge In US Penny Stocks Spotlight
    Oct 16 ZBH Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
    See more AVIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.6
    52 Week Low 2.81
    Average Volume 202,037
    200-Day Moving Average 3.70
    50-Day Moving Average 3.47
    20-Day Moving Average 3.33
    10-Day Moving Average 3.30
    Average True Range 0.14
    RSI (14) 38.27
    ADX 14.45
    +DI 16.21
    -DI 24.85
    Chandelier Exit (Long, 3 ATRs) 3.22
    Chandelier Exit (Short, 3 ATRs) 3.50
    Upper Bollinger Bands 3.55
    Lower Bollinger Band 3.11
    Percent B (%b) 0.11
    BandWidth 13.04
    MACD Line -0.08
    MACD Signal Line -0.06
    MACD Histogram -0.0217
    Fundamentals Value
    Market Cap 263.66 Million
    Num Shares 83.4 Million
    EPS -1.57
    Price-to-Earnings (P/E) Ratio -2.01
    Price-to-Sales 1.90
    Price-to-Book 0.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.26
    Resistance 3 (R3) 3.25 3.20 3.24
    Resistance 2 (R2) 3.20 3.18 3.21 3.24
    Resistance 1 (R1) 3.18 3.16 3.19 3.19 3.23
    Pivot Point 3.14 3.14 3.14 3.14 3.14
    Support 1 (S1) 3.12 3.11 3.13 3.13 3.09
    Support 2 (S2) 3.07 3.10 3.08 3.08
    Support 3 (S3) 3.05 3.07 3.08
    Support 4 (S4) 3.06